Speak up against substandard and falsified medicines! The Fight the Fakes Alliance and its members work collectively to tackle the growing global burden of substandard and falsified medicines to safeguard public health and strengthen health systems.

Type: Startup Activities: deeptech

Aja Pharmaceutical Industries Company was established as one of the Saudi chemical companies, and it is the company known internationally as a leading Saudi joint stock company since its founding in 1972 AD. Aga Pharma owns a factory that is considered a distinctive technological mark among pharmaceutical factories, with its huge capabilities in accordance with the latest internationally known technologies in the field of the pharmaceutical industry. The factory is located in the industrial city of Hail in the north of the Kingdom of Saudi Arabia, and aspires to provide the highest and latest levels of quality in the pharmaceutical …

58 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Roivant aims to improve health by rapidly delivering innovative medicines and technologies to patients. We do this by building Vants – nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying technology. The therapies in development across our family of companies target a wide range of diseases including uterine fibroids, endometriosis, prostate cancer, Parkinson’s disease, diabetes, pulmonary arterial hypertension, and multiple rare and fatal pediatric conditions. We focus on disease areas where the magnitude of R&D investment from industry is disproportionately low relative to societal medical needs. In addition to our biopharmaceutical …

66 similar entities Type: Startup Activities: biotech deeptech

We Chase the Miracles of Science to Improve People’s Lives. Sanofi is an innovative, global biofarmaceutical company, which is guided by one goal, so that according to the slogan "We Chase the Miracles of Science to Improve People’s Lives", focusing on the power of science, change the world for the better. In 100 countries, the teams involved and talented work to change the face of medicine, making impossible possible. The company creates therapies and vaccines that save lives to millions of people around the world. We have a wide range of specialized medicinal products and services in many therapeutic areas …

77 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Innovation for people Created in 1963, Farmaindustria is the National Association of the Pharmaceutical Industry established in Spain. It brings together most of the innovative pharmaceutical laboratories established in Spain, which accounts for almost all sales of prescription drugs under patent in the country. farmacia, investigación y desarrollo, industria, innovación, salud, sanidad, health, pharma, healthcare, laboratorios, medicamentos, fármacos, pharmaceuticals, medicine, I+D, vacunas, vaccines, and industria farmacéutica

79 similar entities Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

We are the association of the pharmaceutical industry of generic medicines in Spain. AESEG is the association of the pharmaceutical industry of generic medicines in Spain and the qualified business interlocutor in this matter. All pharmaceutical specialty laboratories, pharmaceutical raw material and active ingredient manufacturing companies, or technological development companies whose main activity is carried out in the field of generics within the national territory can be members of AESEG. AESEG was established in Barcelona on March 17, 1998 as a national non-profit organization to promote the knowledge and use of generic medicines, creating a true generic culture within Spanish …

56 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Restore health and save lives through innovative medicines Rostra strives urgently to bring novel medicines to patients and clinicians with the power to restore health and save lives globally. Through its novel technology platform, Rostra is developing medicines for infectious diseases with an initial focus on invasive fungal infections. Pharmaceutical Discovery & Drug Development and Infectious Disease

85 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

A Sustainable Platform for Specialty Pharma. As a globally operating company headquartered in Germany, CHEPLAPHARM has established a leading and sustainable platform for specialty pharma during the past two decades. We invest worldwide in well-established pharmaceutical brands which have been developed and introduced by research-based pharmaceutical companies. Our deep expertise in this field enables us to sustain the value of these brands for patients and the medical community. In this way we help the research-based pharmaceutical industry divest from older products so they can focus resources on innovation and new product pipelines. This is how we ACHIEVE MORE together. Specialty …

120 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Vital new drugs for pandemic infections We acquire, develop and license innovative drugs to treat pandemic infections. We have expanded to develop a broader portfolio of new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, our work addresses unmet patient needs and will bring new portfolio of drugs into clinical trials to treat patients suffering from life-threatening infections. Pharmaceuticals, R&D, Antimicrobial Resistance, and Development

147 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

We invent for life! At MSD - known as Merck & Co., Inc. in the United States and Canada, headquartered in Rahway, New Jersey - we are united by our purpose of harnessing the potential of science to save and improve lives around the world. For more than 130 years, we have provided hope through the development of important medicines and vaccines. We aspire to be the world's leading biopharmaceutical research company and are currently at the forefront of research into innovative health solutions to advance the prevention and treatment of human and animal diseases. We foster a diverse and …

237 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities, and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options. See our LinkedIn community guidelines: https://bit.ly/4nAfOZp Idorsia privacy policy: https://www.idorsia.com/legal/privacy-policy

61 similar entities Type: Startup Activities: biotech Technologies: Synthetic Biology

Integrated CDMO & Consultancy | Cell & Gene Therapy Experts | From CMC Strategy to GMP Manufacturing & Facility Design eXmoor Pharma is the only integrated UK cell and gene therapy CDMO with consultancy expertise embedded at every stage of your journey, from early-phase strategy through GMP manufacturing to commercialisation. For over 20 years, we have provided specialised CMC consulting, process development, and GMP clinical manufacturing to more than 170 clients. Our industry-leading scientists and strategists help biotech and pharma companies accelerate innovation while reducing risk and costs. Our purpose-built process development and GMP manufacturing facility offers end-to-end solutions across …

168 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Guiding Pharmaceutical and Consumer Healthcare Companies to Success Pharmaceutical and consumer healthcare companies work within dynamic, sometimes unpredictable, regulatory and commercial environments. Pinney Associates' multidisciplinary teams anticipate your scientific and policy obstacles while guiding you toward regulatory and marketplace success. Pharmaceuticals, Risk Management, Abuse Liability Testing, Rx to OTC Switch, In vitro, Abuse potential assessment, Consumer healthcare, Consumer insights, Business development, FDA, CNS active drugs, Regulatory, Over-the-counter medicines, OTCs, Nonprescription drugs, Dietary supplements, Regulatory Strategy, Clinical Development, Eight Factor Analysis 8FA, Abuse Deterrent Formulation Evaluation, Postmarketing Surveillance, Risk Evaluation and Mitigation Strategies, REMS, Target Product Profiles, Scientific Assessment and Review, …

103 similar entities Type: SMB Activities: biotech deeptech martech regtech Technologies: Synthetic Biology

MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies. Our team of 300+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe. The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees …

258 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Pragati Healthcare India is a global exporter and distributor of Anti-cancer, Diabetes, Hepatitis, Cardiac, Sexual Health, HIV, Ophthalmic and OTC products. Our family has been into pharmaceutical distribution for over 50 years now and have significant presence in UK & Hong Kong. We have direct tie ups with reputed pharma companies like Pfizer, AstraZeneca, Novartis, Novo Nordisk, Eli Lilly, Bayer, Abbott, Boehringer Ingelheim, Sanofi, Sun Pharma, Natco, Cipla, Lupin, Intas and others. For other companies, we source from vendors after careful research about their repute and history. Cancer Medicines Exporter, Unlicensed Medicines, Parallel Exports, Europe Medicine Supplier, Named Patient Medication, …

60 similar entities Type: Startup Activities: biotech deeptech

HILLEMAN LABORATORIES IS COMMITTED TO DEVELOPING HIGH IMPACT, AFFORDABLE VACCINES FOR PEOPLE IN DEVELOPING COUNTRIES. A first-of-its-kind initiative, Hilleman Laboratories is an equal joint-venture partnership formed between Merck & Co., a global research-driven pharmaceutical company and Wellcome Trust, a global charitable foundation dedicated to human and animal health. Headquartered in India, Hilleman Laboratories is a not-for-profit organization leveraging a cadre of talented scientists from around the globe. The MSD Wellcome Trust Hilleman Laboratories is committed to developing high impact, affordable vaccines for people in developing countries in an innovative and sustainable manner. The work of the Hilleman Laboratories will focus …

61 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

From research to patients: safer, smarter, faster. 3Biotech provides Innovative solutions continuously to challenge, support and accelerate the manufacturing of safe drug candidates. We are your colleagues, partner for the Chemistry, Manufacturing and Control (CMC) to succeed in your project and mission to create a new future and impact patient outcomes. Our Three Pillars are: 1.Safety 2. Efficacy 3. Manufacturing These are our drivers to secure all steps from the research to the first in human stage with the most innovative project strategy and plan of execution. We have implemented a human and customer centric organization to provide the best …

124 similar entities Type: Startup Activities: biotech deeptech fintech manufacturing regtech Technologies: Synthetic Biology

Innovative Process Solutions IPSOMEDIC is a pharmaceutical development company, specializing in innovation in the manufacturing of active pharmaceutical ingredients (APIs). Our objective is to give countries the possibility to reach their pharmaceutical independance. We design tailor-made processes for all stages of industrial production, to become cost efficient, environmental-friendly, and safe: - Continuous chemical reaction - Continuous purification - Continuous crystallization Innovation, Chemical processes, drug substance, and Continuous processes

89 similar entities Type: Startup Activities: manufacturing industry 4.0 Technologies: Synthetic Biology

The Medicine Maker celebrates the people, processes and vision that bring new drugs and biologics to market. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond. pharmaceutical , biopharmaceutical, bioprocess, upstream, downstream, formulation, drug delivery, and dosage form

63 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

The Future of Repositioning Pharma Equity Group, a listed company on the Nasdaq Copenhagen stock exchange, is fully dedicated to advancing the medical projects of its subsidiary, Reponex Pharmaceuticals A/S. With an unwavering focus on healthcare, Pharma Equity Group's primary objective is to bring significant value to Reponex Pharmaceuticals' medical projects. The company is committed to providing extensive support, resources, and expertise to drive the development and success of these projects. As a strategic partner, Pharma Equity Group works closely with Reponex Pharmaceuticals, prioritizing the advancement of innovative medical solutions and breakthrough therapies. Every effort is currently directed towards ensuring …

58 similar entities Type: SMB Activities: healthtech deeptech biotech

Excellence in reproductive health The Vitrolife Group is a world-leading global provider of medical devices and genetic testing testing solutions. Dedicated to the reproductive-health market since 1994, we have grown by focusing on product development, groundbreaking research, consistent quality control and acquisitions of innovative companies in the industry. In 2021, Vitrolife acquired Igenomix, a leader in reproductive genetic testing services primarily for IVF clinics. Together we are now the Vitrolife Group, a global leader in reproductive health focused on supporting our customers and patients worldwide to improve treatment outcomes – always with sustainability in mind. Based on science and advanced …

83 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Medicines for Europe represents the generic, biosimilar and value-added medicines industries across Europe. Its vision is to provide sustainable access to high quality medicines, based on 5 important pillars: patients, quality, value, sustainability and partnership. Its members directly employ 190,000 people at over 400 manufacturing and 126 R&D sites in Europe and invest up to 17% of their turnover in R&D investment. Medicines for Europe member companies across Europe are both increasing access to medicines and driving improved health outcomes. They play a key role in creating sustainable European healthcare systems by continuing to provide high quality, effective generic medicines, …

61 similar entities Type: SMB Activities: biotech deeptech Technologies: Decarbonization

Victorian industry association providing a focal point for connectivity and leadership across the Health Industry BioMelbourne Network’s mission is to foster the development of an advanced, innovation driven and sustainable health industry. As a for-purpose, industry led membership association, we encompass biotechnology, medical technology, pharmaceuticals and health innovation companies in the state of Victoria. We connect business, research, finance, health and government to support and promote the sector’s growth and facilitate the development and commercialisation of new drugs, devices, diagnostics and digital health technologies in Victoria. Since 2001, we have championed an environment that enables Victorian organisations to innovate, commercialise …

63 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Solving fake and falsified medicines. Solving the $200billion epidemic of fake and falsified medicine Trade in counterfeited and falsified drugs has reached over 200 Billion dollars and the WHO warns that this problem is going to get worse. Hundreds of thousands of deaths are caused by faked and falsified drugs in Africa every year. We help Pharmaceuticals comply with track and trace to fight fake and falsified drugs.

60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Otsuka Pharmaceutical is a global healthcare company with a guiding motto: “Otsuka – people creating products for better health in the world.” At Otsuka we research, develop, manufacture and market innovative products to address unmet medical needs and nutraceutical products for the maintenance of daily health. We focus our efforts mainly in the area of ​​Mental Health and Nephrology, as well as we have research programs in several poorly addressed diseases, including oncohematological pathologies or multidrug-resistant tuberculosis, an important challenge for global public health. Otsuka is made up of 34,400 people in 32 countries around the world, 168 companies, 34 …

63 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Within the Chugai Pharmaceutical Group, Chugai Pharmaceutical Industries is responsible for development and production functions. We receive the manufacturing process for investigational drugs and products from Chugai Pharmaceutical, create methods and systems that can actually be produced at our factories, and perform quality control and evaluation. In this way, we play an essential role in turning medicines from the idea stage into real products that benefit patients. Pharmaceuticals, new drug development, global companies, biopharmaceuticals, small and medium molecule drugs, pharmaceutical manufacturing, production technology, IT engineers, engineers, quality control, and quality assurance

80 similar entities Type: SMB Activities: it services Technologies: Synthetic Biology

Xbrane is a leading science based biosimilar developer of cost effective medicines with high unmet medical need Xbrane is a biopharmaceutical company specialized in high demand biosimilars and long acting injectables. We enable global health equality by bringing affordable drugs to treat underserved people suffering from critical diseases. Xbrane posses world leading expertise in developing true generics for injectable controlled release drugs and proprietary high-yield protein expression technology. Complex generics, Protein expression, Biosimilars, Controlled release, Strain development, and Formulation

112 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

NEW FRONTIERS IN NEUROSCIENCE Neurentis PLC is a late-clinical stage UK specialty pharma company, focusing on neuroscience and specialising in the development of novel treatments for mental health and other neurological and psychiatric diseases. Our product pipeline is balanced with an advanced lead drug for the treatment of Treatment-Resistant Depression (TRD) in the last stages of drug development as well as earlier stage drug candidates in collaboration with research institutions and other companies. The company is run by experienced ex-pharma industry executives, with more than 35 years’ experience in the sector each. The company’s low-risk commercial strategy is to commercialize …

382 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Anything is Druggable - with Quantum Accuracy Qubit Pharmaceuticals brings unparalleled accuracy and precision to drug discovery and design, using quantum physics to develop life-changing treatments for major diseases. We leverage our technologies and expertise to advance 7 fully owned drug discovery programs focusing on cancer resistance and escapement, a growing concern in aging populations, and chronic inflammatory diseases. We also co-develop programs with academia and pharmaceutical partners. Our proprietary ATLAS drug discovery platform unites our technologies based on 30 years of research from renowned scientists and founders, Louis Lagardère (Sorbonne University and CNRS), Matthieu Montes (CNAM), Jean-Philip Piquemal (Sorbonne …

284 similar entities Tags: FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

AI-native pharmaceutical company We are an AI-native pharmaceutical company transforming scientific innovation from Africa and the UK into high-impact global health solutions. By combining cutting-edge artificial intelligence with regional biomedical expertise, we accelerate drug discovery and development—turning underutilized insights into scalable therapeutic assets. Our mission is to close the innovation gap, reduce R&D timelines, and deliver next-generation treatments to patients worldwide.

184 similar entities Type: Startup Activities: biotech healthtech Technologies: A.I.

Our mission for +25 years is to take care of people's health with an eye toward the future and innovation. We are moved by values ​​such as commitment, honesty and the desire to improve. Thanks to them and our team we have become the 3rd pharmaceutical laboratory that sells the most units in Spanish pharmacies. We are also pioneers in biosimilar drugs in Spain and Portugal and we also have a line of self-care products, sports nutrition under the Finisher brand and women's health under the Gynea brand. Our vocation to serve society means that we are always close to …

271 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Extem Bioscience has been developing advanced technologies for the use of regenerative medicines and is expanding our offerings. We have identified 3 key areas that will undergo drastic shifts over the next 10 years and are in need of a multidisciplinary evidence based approach. By collaborating and co-developing with leading institutions within North America we see a brighter, healthier and trans formative future.

60 similar entities Type: Startup Activities: biotech deeptech

Vaccines against antibiotic-resistant infections Headquartered in Seville, Spain, Vaxdyn works with an international network of collaborators in the development of multi-pathogen vaccines for preventing antibiotics-resistant infections in all regions of the world. Our vaccines target high-risk populations, population affected by chronic diseases of the lungs, liver, kidney, immunocompromised by co-morbidities like diabetes or cancer, populations associated with nursing homes and hospital settings, women affected by recurrent urinary-tract infections, or neonates. We are strongly committed to contribute to reducing antibiotic use in the world by following a One-Health approach. Vaxdyn is the first Spanish biotech funded by CARB-X. CARB-X awarded Vaxdyn …

76 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Transforming science into drug success stories Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly.​ Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty.​ We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible. Translational research, Biotechnology, Pharmaceuticals, …

225 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Pioneering A New Class of Universal Vaccines Osivax is a clinical-stage biopharmaceutical company developing a portfolio of differentiated influenza vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses, thanks to its novel, self-assembling nanoparticle platform technology, oligoDOMTM. The company’s lead candidate, OVX836, is a broad-spectrum influenza A vaccine candidate currently in Phase 2b clinical trials with over 4,000 volunteers tested and encouraging efficacy proof of concept data. By combining OVX836 with standard flu vaccines, Osivax is advancing toward a best-in-class seasonal flu vaccine to prevent all strains of influenza. Osivax collaborates with leading global health agencies …

66 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We Embrace the Challenge in Science Dompé is a private, family-owned biopharmaceutical company with more than 130 years of independent history, focused on redefining treatments for ophthalmic, neurological, and pain-related conditions through breakthrough science. As the first company to unlock the therapeutic potential of nerve growth factor (NGF), Dompé is advancing first-in-class, disease-modifying therapies that target the underlying causes of nerve damage rather than symptoms alone. Building on Nobel Prize-winning science, our work has already led to the approval of the first topical biologic in ophthalmology for a rare neurotrophic eye disease, and continues to expand into high-unmet-need areas across …

188 similar entities Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions. We have a strong track record, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines, including the world’s first and only chikungunya vaccine, as well as certain third-party vaccines. …

64 similar entities Type: Startup Activities: biotech healthtech manufacturing Technologies: Synthetic Biology

Pyramid studio embodies an unique way of leading therapeutic innovation to fuel the pipeline of pharmaceutical companies Pyramid Studio is a First-of-its-Kind venture builder dedicated to fuel the pipeline of pharmaceutical companies Pyramid Studio embodies a new way of leading therapeutic innovation through a unique build-to-buy model. Our mission is to bridge the gap for pharmaceutical companies seeking access to breakthrough innovations and delivering new therapies to patients. In practice, our team identifies and rigorously selects groundbreaking innovations from top academic teams across Europe. We collaborate closely with our Pharma partners to co-develop and co-finance these programs, ultimately delivering IND-ready …

293 similar entities Type: Incubators & VCs Startup Activities: deeptech biotech Technologies: Synthetic Biology

Medincell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. The sustainability of MedinCell is an essential condition …

577 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

The Research!America alliance advocates for science, discovery and innovation to achieve better health for all. The Research!America alliance advocates for science, discovery, and innovation to achieve better health for all. We urge Congress and the administration to increase funding for the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Agency for Healthcare Research and Quality (AHRQ), Food and Drug Administration (FDA) and National Science Foundation (NSF) at levels that keep pace with scientific opportunity. We also advocate for federal funding for global health research and a legislative and regulatory climate that stimulates growth in private sector …

56 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Translating genetic discoveries into safe and effective treatments. Arctic Therapeutics is a clinical-stage biopharmaceutical company on a mission to treat and even prevent some of the world’s most pressing diseases by utilizing genetic sequencing to analyze and map the genetic causes of diseases at a granular level, applying our findings to develop effective treatments. Our company was founded by Dr. Hakon Hakonarson in 2015 as a spin-off from the US-based Center for Applied Genomics (CAG), which he launched in 2006 and established it as the largest pediatric biobank and genomic database in the world. We maintain close research relationships with …

368 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Partner of choice in specialty, hospital, and rare disease medicines Partner of choice in specialty, hospital, and rare disease medicines ADVANZ PHARMA is a global pharmaceutical company with the purpose to improve patients’ lives by providing the specialty, hospital, and rare disease medicines they depend on. Our ambition is to be a partner of choice for the commercialisation of specialty, hospital, and rare disease medicines in Europe, Canada, and Australia. In line with our ambition, we are partnering with innovative biopharma and pharmaceutical development companies to bring medicines to patients. Headquartered in London, UK, we have commercial sales in more …

225 similar entities Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Captor Therapeutics is a publicly-listed (WSE:CTX) innovative drug discovery and development company focused on targeting the undruggable proteome using targeted protein degradation. Our mission is to transform lives of patients suffering from cancer, autoimmunity and neurodegenerative diseases. Our groundbreaking technology is perfectly suited to create new drug candidates with the potential to ease patients' burden and cure conditions that so far have only been poorly treatable. Captor Therapeutics S.A. implements projects co-financed by the European Union. All information about the projects is available at: https://captortherapeutics.com/grant-projects. drug development, biotechnology, and protein degradation

734 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Creation and implementation of innovative therapeutic solutions derived from cannabinoid biomolecules. Since the entry into common law of medical cannabis in September 2023, the development of new drugs has been at the center of the pharmaceutical industry's concerns. Chenevia is a French Biotech startup, financed by Breton investors, subsidized by the Brittany Region, supported by Crédit Agricole via the Village by CA Morbihan accelerator and active member of Santé France Cannabis (privileged consultant to the Government on the regulation of medical cannabis). The 3 co-founders have skills combining technique, pharmaceutical expertise and compliance with regulatory constraints. We are committed to …

140 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Revolutionising the delivery of fridge-free pharmaceuticals - StablevaXTM eliminates the need for the global cold chain Stablepharma Ltd is an innovative biopharmaceutical company developing a pipeline of fridge-free vaccine and pharmaceutical products. Stablepharma was founded with a simple purpose; to use its novel technology to dramatically improve health outcomes for those adults and children most at risk of death and disability caused by vaccine preventable diseases. StablevaX is an adaptable fridge-free technology which offers a greatly extended shelf-life, reduces vaccine wastage and CO2 emissions of the global cold-chain. The WHO estimate that approximately 50% of all vaccines manufactured are wasted …

59 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Translating science into global health impact. Translating scientific discoveries into affordable, globally accessible public health solutions. IAVI is a non-profit that develops vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases. AIDS vaccine, research and development, product development partnership, HIV/AIDS, vaccine development, global health, capacity strengthening, clinical trials, and scientific research

81 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

A results-oriented nonprofit dedicated to solving global health issues by forming partnerships with industry. BIO Ventures for Global Health (BVGH) is a Seattle-based nonprofit organization working at the crossroads of the private and public sectors to advance research and improve health. #BVGH #bvghAAI #AC3T BVGH connects people, resources, and ideas across biotechnology and pharmaceutical companies, governments, and nonprofits to solve global health issues. Programmatic activities include accelerating research and development (R&D) for diseases of poverty, expanding access to cancer medicines and technologies in Africa, and building biomedical R&D capacity in low- and middle-income countries (LMICs). global health, Africa, neglected diseases, …

59 similar entities Type: SMB Activities: healthtech biotech deeptech

We were made for this 53Biologics is a end-to-end biologics CDMO built to keep progress moving. By combining scientific expertise, integrated in-house capabilities and a collaborative way of working, we enable confident decision-making as biologics programs evolve. We support your biologic from early development to commercialization. With USP and DSP development, GMP manufacturing, quality control and fill-finish connected under one roof, we reduce handoffs, protect continuity and help clients grow without disruption. We were made for this. Biopharmaceuticals , CDMO, pDNA, Recombinant Protein, GMP, Drug Development, Microbial Manufacturing, Cell Banking, and GMP Manufacturing

353 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Innovating to Enhance Quality of Life Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes. Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, and Neurology

616 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

To make disease-modifying treatments available to patients with serious or life-threatening conditions Medibiofarma S.L is a clinical-stage biotechnology company founded in 2016 by a group of professionals with extensive experience in Drug Discovery in the pharmaceutical industry. We aim to generate innovative and high quality research programs based on the modulation of clinically validated therapeutic targets for the treatment of cancer and non-cancer diseases. Medicinal Chemistry, in vitro Pharmacology, Drug Discovery and Development, IP generation, IBD (Colitis, Crohn), Oncology, CNS, and Synaptopathies

630 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We Craft Care SOMAÍ is a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceutical extract portfolio. At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine. SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that …

62 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Advancing Medecine Together Creapharm is now Myonex - Myonex is an industry leader in global clinical trial supply and pharmaceutical commercial services. Our suite of integrable services and solutions helps pharmaceutical, biotech, and CRO partners advance medicine by reducing time, costs, and complexity. With locations in the US, Germany, UK, and France, our comprehensive, client-focused approach, coupled with expert project management, ensures seamless execution across regions, optimizes supply chain efficiency, and adapts to evolving trial or project needs while delivering quality, flexibility, and global scale. Learn more at www.myonex.com. Clinical GMP Production, Clinical Packaging, Distribution Distribution, International Depot Network, IMP …

211 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Spanish Association of Biosimilar Medicines. BioSim, Spanish Association of Biosimilar Medicines, is a non-profit organization whose aim is to welcome and represent all pharmaceutical companies established in Spain that develop, produce, market or distribute biosimilar medicines. BioSim opens its doors to both laboratories that are already operating in the biosimilars market and to original product companies that have launched, or are going to launch, a biosimilars division; be it for development, production or marketing. It is a new institution, independent of other business associations in the sector, and whose fundamental mission is to integrate, unite and add efforts for the …

58 similar entities Type: Startup Activities: biotech deeptech

Biopharmachem Ireland is a business association within Ibec representing the biopharma and chemical sectors. BioPharmaChem Ireland is the leading representative body for the Biopharma, Pharma and Chemical manufacturing sectors in Ireland. Our membership is composed of the leading global corporations and indigenous Irish companies ranging from Research and Development, Global Business Service Centers, High Value Manufacturing, Headquarters and IP Management and Supply Chain Management. With the support of industry, Ireland will position itself as a recognised centre of excellence for innovation and development in pharmaceutical, biopharmaceutical and chemical supply, thereby becoming the location of choice for the launch of new …

37 similar entities Type: SMB Activities: biotech manufacturing

Policy-relevant research since 1953 NPC serves patients and society with policy-relevant research on the value of patient access to innovative medicines and the importance of scientific advancement. We envision a world where advances in medicine are accessible to patients, valued by society, and sustainably reimbursed by payers to ensure continued innovation. We provide the evidence to bolster the case for the value of innovation through our policy-relevant research. NPC informs policy discussions in the media, in Congressional testimony, and through leading voices sharing our research about the future of innovative medicine and patient access. Real-world evidence, value of pharmaceuticals, health …

43 similar entities Type: SMB Activities: biotech deeptech

AB Science was founded in 2001 by a team of researchers, clinicians and entrepreneurs who have dedicated their lives to discover key mechanisms in life science and develop new drugs targeting these mechanisms to dramatically change the life of patients in the most unmet medical needs. We are innovators and scientific entrepreneurs in the field of life science. Our group is specialized in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical needs in the field of cancers, chronic inflammatory diseases and neurological degenerative disorders. Our pipeline is both in Human and Veterinary medicine. Our drugs are …

370 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Maintain vision and improve ocular health Nicox is an international ophthalmic R&D company, aiming to build a diversified portfolio of therapeutic products addressing the needs of eyecare practitioners and patients around the world. Our global growth strategy is focused on outstanding international collaborations and on our proprietary programs including those from our nitric oxide-donating research platform. For more information please visit www.nicox.com Pharmaceuticals, Ophthalmology, and Research and Development

248 similar entities Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology

#BeyondBoundaries At Sygnature Discovery, a global drug discovery CRO, we create exceptional scientific outcomes. For our customers, who bring life-changing medicines to patients; and for our people, who help make this possible. We’re 700+ scientists from over 50 countries, working as one across Europe and North America. With no competing internal programs, we offer total confidentiality and commitment. Over the past 20 years, we’ve earned a track record of real impact: 60+ advanced candidates, 200+ patents filed, 200+ active projects. Over 90% of our customers choose to stay with us – from biotechs racing to clinic to pharma companies that …

271 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Transforming lives with groundbreaking treatments Coultreon Biopharma's mission (formerly Onco3R Therapeutics) is to develop life-changing medicines for patients affected by chronic inflammatory diseases of high unmet medical needs. The team is leveraging their knowledge and expertise to bring transformative innovations to patients suffering from auto-immune diseases. In this field, there is an urgent need for more convenient oral drugs that can offer greater efficacy with a better safety profile. Drug Discovery, Drug Development, Immunology, Biotech, and R&D

826 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

a wholly owned subsidiary of Eli Lilly and Company LimmaTech Biologics AG, a wholly owned subsidiary of Eli Lilly and Company, is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. vaccines, research & development, biotechnology, and antimicrobial resistance

419 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Find Your Next Blockbuster - Your single platform for accurate, objective, and timely intelligence Global biopharmaceutical drug patent and generic entry business intelligence. DrugPatentWatch Supports Critical Business Decisions: >Payers: Formulary and pharmacy & therapeutics (P&T) Anticipate future budget requirements and proactively identify generic sources > Branded pharmaceutical manufacturers Assess past successes of patent challengers and elucidate research paths of competitors > Generic manufacturers Inform portfolio management decisions on future drug development > Buyers, wholesalers, and distributors Predict branded drug patent expiration, identify generic suppliers, and prevent overstock of branded drugs > API manufacturers Obtain formulation and manufacturing information; identify final …

56 similar entities Type: SMB Activities: deeptech biotech legaltech Technologies: Data Analytics

Let's bring medicines to the world, because the world is waiting NDA Group is the regulatory powerhouse of SSI Strategy. For more than 25 years we’ve leveraged our extensive experience and global network to help you optimize your regulatory strategies, expedite filings, and secure successful approvals in key markets worldwide. By integrating our regulatory proficiency with SSI Strategy's strategic capabilities in clinical development, medical affairs and commercial planning, we provide biotech companies with a holistic solution that maximizes the value of their assets and ensures timely access to innovative therapies. We understand that bringing a new therapy to market is …

95 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

The Task Force for Global Health is a global health nonprofit working with partners in nearly 140 countries. The Task Force for Global Health, based in Atlanta and founded in 1984, works with partners in nearly 140 countries to address the world’s most serious and emerging global health threats and strengthen the systems that protect and promote health. We envision a world in which everyone has the opportunity to lead healthy lives free from preventable suffering, disability and death. Learn more about our work at www.taskforce.org. Global Health, Supply chain, Drug Donation Programs, Public Health Informatics, Health Systems Strengthening, and …

107 similar entities Type: SMB Activities: healthtech transporttech Technologies: Synthetic Biology

We develop, optimise and distribute innovative pharmaceutical products that offer a unique solution Who we are: Green Park Pharma UK Ltd. is a pharmaceutical company specialising in innovative drug delivery formulations. Our products address a significant market need across major global markets where the team has successfully operated. Our mission: Our mission is to develop, optimise and distribute innovative pharmaceutical products that offer a unique solution for unmet patient needs across all major global markets. Learn more about us and get in touch

282 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Zerion Pharma is a pharmaceutical company transforming the landscape for formulation of poorly soluble drugs Zerion is a pharmaceutical company transforming the pharmaceutical landscape for formulation of poorly soluble drugs that are currently not reaching their therapeutic potential. Through the use of our proprietary formulation platform, we aim to develop new treatment options for patients across all small molecule therapy areas. We are focused on improving existing drug products by building an internal pipeline, while partnering with originators to enable their early stage drug molecules, striving to improve the lives of patients around the world. Pharmaceuticals, Formulation, and Drug delivery

184 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unlocking the potential of cannabis medicines for those who need it. Unlocking the potential of cannabis medicines for those who need it. Our Market Access Team launches medical cannabis producers'​ businesses into new markets to create long-term value for them. Our R&D Team creates new technologies for medical cannabis producers to create better, cost-effective, accessible medicines for patients. By combining our strengths as scientists, technologists, and commercial strategists, we create game-changing Intellectual Property that will transform the fastest growing industry in the world, medical cannabis. Find all our links at: https://growgroup.komi.io Cannabis Biotech, Medical Cannabis, Research & Development, Technology, Biotech, …

61 similar entities Type: Startup Activities: deeptech healthtech manufacturing

An industry trade organization for manufacturers of active pharmaceutical ingredients, intermediates and excipients. The Bulk Pharmaceuticals Task Force (BPTF) is an industry trade organization representing manufacturers of active pharmaceutical ingredients, intermediates and excipients. BPTF addresses regulatory and plant operations issues related to current Good Manufacturing Practices compliance. BPTF establishes sound working relationships with regulators, allied industries and the public and serves as a reliable source for the development and implementation of balanced regulations and industry guidance resources. BPTF undertakes this advocacy on behalf of its member companies to achieve drug product and drug substance supply chain safety for consumers.

58 similar entities Type: SMB Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

Moving pharmaceutical companies to expand access to their products in low- & middle-income countries The Access to Medicine Foundation is an independent non-profit organisation based in the Netherlands. We seek to transform the healthcare ecosystem by motivating and mobilising companies to expand access to their essential healthcare products in low- and middle-income countries. Over the past two decades, we have demonstrated the power of data, collaboration and persuasion to trigger action by the pharmaceutical industry and scale up access to products. Our tried-and-tested approach involves defining the actions that healthcare companies should take, analysing what companies are actually doing, and …

117 similar entities Type: SMB Activities: healthtech civictech deeptech biotech Technologies: Synthetic Biology

Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, …

589 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

From lab to life mAbxience is a Spanish-based company specializing in the development, production, and commercialization of biopharmaceuticals. With over a decade of expertise, our mission is clear: to provide accessible, affordable medicines across the globe, aiming to enhance the quality of life by ensuring universal access to high-caliber medicines. With two market-approved products and a robust pipeline in development, we have established a B2B presence in over 100 markets. Alongside this, we have formed a network with more than 30 partners and built a dedicated team of over 1,000 professionals. Our three multi-product facilities, located in Europe and South …

202 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Ending malaria, rewriting the future MMV is a leading product development partnership (PDP) in the field of antimalarial drug research and development. Our vision is a world in which innovative medicines will cure and protect the vulnerable and under-served populations at risk of malaria, and ultimately help to eradicate this terrible disease. Our success in research and access & product management comes from our extensive partnership network of over 375 pharmaceutical, academic and endemic-country partners in 50 countries. www.mmv.org www.facebook.com/medicinesformalaria www.twitter.com/medsformalaria www.youtube.com/user/MMVmeds4malaria http://plus.google.com/+mmvorgmedsformalaria Research and Development, Product Development Partnership (PDP), Medicines, and Malaria

110 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

More than 55 years working to ensure people have access to their medications, regardless of prevalence. For over 50 years, we have worked to ensure that everyone has access to our medications, regardless of their prevalence, thus improving their quality of life. #WeAreRubió Laboratorios Rubió was founded in 1968 with the goal of marketing medications that, at the time, were not available in our country because they were treatments for low-prevalence diseases. As pioneers in the first drug in Spain for the treatment of ADHD, today we have more than a dozen medications on the market, many of which are …

91 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Ilya Pharma 🇸🇪🇺🇸 is bringing local-acting immunotherapies to patients Delivering local-acting immunotherapies to patients ATMP, Gene Therapy, Drug development, Clinical trials, GMP, IBD, Wound treatment, Scar, Topical, Oral, Research, Science, Immunology, Immunophysiology, microbiology, Applied microbiology, Regulatory excellence, Skin, Diabetes, IBD, Cysticfibrosis, SAVI, colitis, Cystic fibrosis, and Inhalation

646 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Rappresentiamo l'industria dei farmaci accessibili in Italia per un accesso equo alle cure Egualia (formerly Assogenerici) is the Italian Federation of Industries for Accessible Medicines which today represents more than fifty companies, over 95% of the companies producing generic, biosimilar and value-added medicines. Founded in 1993, it is a member of the European association of the sector, Medicines for Europe, and welcomes multinational and Italian companies present throughout the territory, which produce both for the domestic and foreign markets, as well as companies engaged in the production of drugs on behalf of third parties for the entire pharmaceutical industry. Generics …

76 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

At the service of health and the citizen: from research to medicines. The Italian Society of Pharmacology (SIF) is a non-profit scientific association, recognized by the Ministry of University and Research. The SIF brings together pharmacologists and pharmacology experts from the Italian academic community, from the world of public and private research and from the pharmaceutical industry. Founded in 1939, today the Society is led by a President-in-Office, a President-Elect, a Past President and a Board of Directors made up of seven members, among whom a Secretary is elected. Mission: • promote research in the field of basic, applied and …

58 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Partnering India since pre-independence to improve patient safety & provide healthcare access to all. #BharatKeLiye The Organisation of Pharmaceutical Producers of India (OPPI) was established in 1965 and represents the research-based pharmaceutical companies in India. OPPI remains committed to supporting the nation’s healthcare objectives and collaborating with all stakeholders to find sustainable solutions. OPPI believes the need for innovation must be balanced with the necessity for more accessible medicines, within a robust IP environment. Vision: OPPI is an organisation of research and innovation driven pharmaceutical companies committed to addressing India's healthcare needs by: - Facilitating greater access to quality healthcare …

61 similar entities Type: SMB Activities: healthtech deeptech biotech Technologies: Synthetic Biology

As a global life science company, taking care of human, animal and plant life has been our priority for 50 years.Today, we are a world leader in the production of heparin – the primary anticoagulant used to save approximately 100 million lives every year. We have also set the benchmark for the manufacture of APIs and functional ingredients for the pharmaceutical, nutraceutical, veterinary, animal nutrition and agricultural sectors. We work to innovate in human, animal, and plant health. Discover our work and follow us on our LinkedIn pages: https://www.linkedin.com/showcase/bioiberica-animal-health https://www.linkedin.com/showcase/bioiberica-human-health https://www.linkedin.com/showcase/bioiberica-plant-health We believe that partnership is the key to success …

120 similar entities Type: SMB Activities: deeptech biotech

Improving the lives of patients with next generation therapies for cancer and respiratory disease, including COVID-19. APEIRON Biologics is a privately held European biotech company based in Vienna, Austria, focused on the discovery and development of treatments for respiratory diseases and novel cancer immunotherapies. Our company has a well balanced portfolio with one product on the market and several promising products from clinical to pre-clinical stages. As for the product on the market, APEIRON received EU marketing approval for APN311 (Dinutuximab beta, Qarziba®) in May 2017 for the treatment of pediatric neuroblastoma patients. We out-licensed Qarziba® globally to EUSA Pharma …

70 similar entities Type: SMB Activities: biotech deeptech

Delivering Excellence in Life Sciences Jenburkt Pharmaceuticals Limited is a healthcare organization listed on the Bombay Stock Exchange and headquartered in Mumbai, with four decades of unwavering commitment to putting patients first in everything we do. Founded in 1984 and deeply rooted in Indian values of service and compassion, over the past 40 years we have evolved into a trusted name in the pharmaceutical landscape, driving leadership in primary care and pioneers in pain management. Our Patient-First philosophy drives every decision, from our WHO-GMP approved state-of-the-art manufacturing facility in Sihor, Gujarat, to our in-house R&D Center approved by the Ministry …

90 similar entities Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

What we provide is essential We are a pharmaceutical company dedicated to prioritizing essential medicines and aspiring to improve the health of millions of people around the world. Since our establishment in 2008, our portfolio has grown through the acquisition of 'princeps' medicines from major pharmaceutical companies. We focus on essential medicines recognized by the medical community for their therapeutic value, ensuring their production, marketing, and promotion to healthcare professionals. In doing so, we contribute each year to improving the health of over 2.5 million patients worldwide. Juvisé Pharmaceuticals is now an internationally recognized company, with medicines in neuroscience, gastroenterology, …

224 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Fueled by Connections to Transform Rare DiseasesTM Agios is a commercial-stage biopharmaceutical company dedicated to redefining the future of rare disease treatment. Fueled by connections, we build trusted partnerships with rare disease communities, collaborating to develop and deliver innovative medicines with the potential to transform lives. Rooted in hematology, we combine deep biological expertise with real-world insights to advance a growing pipeline of medicines that reflect patients’ priorities. Our inclusive, collaborative culture sparks bold thinking and strengthens our connections – with each other and with the people we serve. Review our social media guidelines: https://www.agios.com/community-guidelines/ Biopharmaceuticals, Cellular Metabolism, and Rare …

312 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

MSD, known in the United States and Canada as Merck & Co., Inc., with headquarters in Kenilworth, (New Jersey, USA), is an American multinational leader in the pharmaceutical sector. For over 65 years in Italy and 130 in the world, we have revolutionized therapeutic paradigms for dozens of pathologies through the discovery of over 200 innovative molecules. Our mission is to discover, develop and make available innovative products and services that save and improve the lives of Patients around the world, without ever forgetting that medicines are for People, not for profit. In Italy, we are present with an office …

63 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Serving patients is a privilege that comes with significant responsibilities. Civica Rx was created in late 2018 to secure the supply of important medicines hospitals use every day. As of Q2 2024, we have provided over 180 million units of essential medicines to hospitals, enough to help treat over 80 million patients. Recently, we announced we will manufacture and distribute affordable medications for consumers in an outpatient/retail setting, including affordable insulin. Insulin is an exciting project as we are partnering with nearly every corner of the diabetes ecosystem to bring low-cost insulin to people living with diabetes at no more …

107 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: Synthetic Biology

We’re changing the way the world treats inflammation and the way the pharma industry treats humanity Join the revolution! We’re changing the way the world treats inflammation and the way the pharma industry treats humanity. Invest today → https://wefunder.com/senjam Sen-Jam's Global scientists have developed a multi-indication patent and FDA-pending product for the prevention of pain and flu-like symptoms for indications not currently being addressed by the FDA OTC Drug Monograph. It's time for a stronger, more resilient world, free of side-effects and filled with living remarkably Inflammation , Wellbeing, Pain Relief, pharmaceutical, and healthcare

86 similar entities Type: Startup Activities: deeptech healthtech biotech Technologies: Synthetic Biology

Tanabe Pharma America, Inc., previously Mitsubishi Tanabe Pharma America, Inc., was launched in 2016 as a wholly-owned subsidiary of what is now Tanabe Pharma Corporation – one of the world’s oldest pharmaceutical companies. Driving scientific discovery and innovation is at the center of everything we do, and it’s more than just a passion – it’s a commitment. Tanabe Pharma America is charged with developing and advancing our pipeline as well as commercializing approved pharmaceutical products in North America. Please see our LinkedIn community guidelines here: http://www.us.tanabe-pharma.com/pdf/LinkedIn-Community-Guidelines.pdf pharmaceutical products, rare disease, innovation, research and development, and global business

167 similar entities Type: Startup Activities: manufacturing deeptech biotech Technologies: IoT

Kyowa Kirin North America is a specialty pharmaceutical company dedicated to making a profound impact on patient lives. Kyowa Kirin is a global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines. We work on some of the hardest to treat diseases where need is high, and potential for life-changing impact is possible. The North America organization includes offices in Princeton, NJ; Toronto, Canada and a research facility in La Jolla, CA. Together, we work as a collaborative team to understand clinical needs and advance innovations that have a profound impact on patient lives. Our growth …

179 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory

418 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

The Cell Therapy Venture Builder MedXCell is a European cell therapy venture builder with a strong industrial mindset and a global perspective. Our focus is on technologies, techniques or novel applications in major diseases such as cancer, autoimmune, neurological and degenerative disorders. Established in 2018, we have offices in Switzerland, the EU (France) and the US (Cambridge, MA) and a multidisciplinary expert team with entrepreneurial, clinical, operational, business development and funding capabilities. Biotechnology, Cell Therapy, Immunotherapy, NK Cells, Mesenchymal Stromal Cells, Immuno-oncology, and Osteoarthritis

582 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Established in 2010 Orange Biotech Private Limited is a prominent Indian Pharmaceutical company best known as Pharmaceutical Medicines exporter and supplier. The company is integrated in producing high quality pharma products focusing on unique, pioneering and qualitative range of Antibiotic, Injectable, Syrups and suspensions. Orange Biotech is a prominent WHO GMP certified ISO 9001:2008. The medications provided are acknowledged for quality, virtue and viability. To provide access to the best high quality healthcare products at affordable prices to everyone thereby improving and enhancing the quality of life. To become the most prominent pharmaceutical company with the highest level of operational …

58 similar entities Type: Startup Activities: biotech deeptech

Accelerating Access to Medicines. For All Axmed is a medicines marketplace that unlocks access to life-saving therapeutics by aggregating demand across healthcare providers (governments, INGOs, private providers). Our business model strengthens purchasing power with manufacturers to ensure the supply of cost-effective, high-quality medicines to patients at transparent prices. We partner exclusively with authorized, high quality pharmaceutical companies and certified caregivers to accelerate sustainable access to medicines . medicines, healthcare, health systems strengthening, and access

111 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

AfricaBio is an independent, non-profit biotechnology stakeholders association. Its key role is to provide accurate information and create awareness, understanding as well as knowledge on biotechnology and biosafety in South Africa and the African region.

58 similar entities Type: SMB Activities: biotech deeptech

Science Driven Development and Analytical Support - From Early Development to Commercialization. Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large …

257 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Essential Pharma is an international specialty pharmaceutical company dedicated to maintaining access to clinically differentiated, niche medicines in small patient populations. Our high-impact portfolio has a focus on the central nervous system (CNS), gastroenterology, ophthalmology, and rare disease, and our products treat patients in more than 70 countries. We are proactive in identifying low volume, difficult-to-manufacture therapeutic products, and late-stage clinical development assets that target rare diseases. We specialise in the acquisition of mature, established, branded medicines that are at risk of shortages or discontinuation, working with partners across the globe to ensure their continued manufacture to the highest standards. …

106 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Working to keep you healthy. The MIP Pharma Group (MIP Pharma) produces and sells prescription-only generics, specifically antibiotics, over-the-counter medicines and medical devices. The main markets are Germany and Poland and some other Eastern European markets. MIP Pharma has two production facilities in Saarland/Germany. With around 250 employees, MIP Pharma realised a total turnover of more than €40 million during the last business year. Contact: info@mip-pharma.de Generika, Antibiotika, OTC-Arzneimittel, and Medizinprodukte

63 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

Plexus Ventures is a prominent healthcare advisory boutique. Our team of professionals are located in markets all over the world – the United States, Europe, and the Asia-Pacific market, including China and Japan – enabling us to combine local knowledge with global reach. pharmaceutical, drug delivery, biotechnology, consumer & OTC, business development & consulting, out-licensing, in-licensing, divestments, acquisitions, global pharmaceutical market experts, marketing & sales, project management, biosimilars, medical device, and consultants

301 similar entities Type: SMB Activities: healthtech Technologies: Synthetic Biology

At the Forefront of the Battle Against HIV MHRP is at the forefront of the battle against HIV. Our mission is to protect U.S. Service Members from HIV and improve global health by conducting research to develop an HIV vaccine, reduce new infections and advance strategies to induce long-term HIV remission. With an international network of research sites throughout Africa and Asia, the program’s growth and success has been achieved through a combination of strong science, careful development of research sites and partnerships with key research institutions in the U.S. and host countries. Since its inception in 1986, MHRP has …

56 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Driving Innovation in Health At Farmalider, we believe in ideas as a driving force for progress. We know that true innovation comes from merging a brilliant idea with the ability to transform it into real improvements in people's health. With over 39 years of experience as a pioneering strategic partner in pharmaceutical innovation, we offer a comprehensive service that spans from ideation and development to intellectual property, licensing, manufacturing, and supply. Our commitment to continuous improvement, solid knowledge, and adaptability allows us to make a difference every day, building sustainable relationships with our clients. For this reason, we offer both …

133 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

#BeyondBoundaries At Sygnature Discovery, a global drug discovery CRO, we create exceptional scientific outcomes. For our customers, who bring life-changing medicines to patients; and for our people, who help make this possible. We’re 700+ scientists from over 50 countries, working as one across Europe and North America. With no competing internal programs, we offer total confidentiality and commitment. Over the past 20 years, we’ve earned a track record of real impact: 60+ advanced candidates, 200+ patents filed, 200+ active projects. Over 90% of our customers choose to stay with us – from biotechs racing to clinic to pharma companies that …

279 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

We seek to make life easier for professionals who work in medicinal laboratories. Boxes of medicines with high quality standards, the best delivery dates, and taking care of the environment. Secondary Packaging for Pharmaceutical Industry

34 similar entities Type: SMB Activities: biotech